BAYER
BAYRYDrugs in Pipeline
374
Phase 3 Programs
210
Upcoming Catalysts
5
Next Catalyst
Next month
Market Overview
Stock performance and key metrics
5 upcoming, 2 past
Low-molecular-weight heparin
Neoplasm
Finerenone (Kerendia, BAY94-8862)
Chronic Kidney Disease
Oxybutynin (Oxytrol, BAY839380)
Overactive Bladder
Amikacin Inhalation Solution (BAY41-6551)
Pneumonia, Bacterial
Gadopentetate dimeglumine (Magnevist, BAY86-4882)
Peripheral Vascular Disease
Ventavis (Iloprost, BAYQ6256)
Hypertension, Pulmonary
Rivaroxaban (Xarelto, BAY59-7939)
Pulmonary Embolism
Gadobutrol (Gadavist, Gadovist, BAY86-4875)
Vascular Diseases
EE20/DRSP(BAY86-5300)
Endometriosis
Acetylsalicyclic acid (Fast release Aspirin, BAY1019036)
Healthy Subjects
Elinzanetant (BAY3427080)
Vasomotor Symptoms Associated With Menopause
YAZ (DRSP 3 mg/EE 0.02 mg, BAY86-5300)
Contraception
Rogaratinib (BAY1163877)
Carcinoma, Transitional Cell
EV/DNG (Qlaira, BAY86-5027, SH T00658ID)
Contraception
Damoctocog alfa pegol (Jivi, BAY94-9027)
Treatment of Bleeding
Finerenone
Chronic Kidney Disease
Enoxaparin followed by VKA
Venous Thrombosis
Levitra (Vardenafil, BAY38-9456)
Erectile Dysfunction
Estradiol valerate, Dienogest (Natazia, Qlaira, BAY86-5027)
Primary Dysmenorrhea
EV/DNG (Qlaira, Natazia, BAY86-5027)
Metrorrhagia
Radium-223 dichloride (BAY88-8223)
Prostatic Neoplasms
Clotrimazole, vaginal ovule
Clotrimazole
LNG-IUS (BAY 86-5028)
Contraception
Gadoteridol (ProHance)
Diagnostic Imaging
Unfractionated heparin
Deep Vein Thrombosis
Nifedipine GITS/Candesartan Cilexetil FDC(BAY98-7106)
Hypertension
Recombinant Factor VIII (Kovaltry, BAY81-8973)
Haemophilia A
Tedizolid (BAY119-2631)
Bacterial Infections
Skyla (Levonorgestrel, BAY86-5028)
Contraception
Avelox (Moxifloxacin, BAY12-8039)
Infectious Diseases
BAY86-6150
Hemophilia A, Hemophilia B
Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
Macular Edema
VEGF Trap-Eye (BAY86-5321)
Myopia, Pathological
Molidustat (BAY85-3934)
Anemia
Angeliq (Drospirenone/17ß-estradiol, BAY86-4891)
Vasomotor Symptoms
Gadoxetic Acid Disodium (Primovist, BAY86-4873)
Known or Suspected Focal Liver Lesions
Darbepoetin alfa
Anemia
Testogel (Testosterone, BAYV001915)
Androgens (Deficiency)
Minisiston (SH D00342A)
Contraception
Gadoterate meglumine
Contrast Enhancement in Magnetic Resonance Imaging
Omeprazole/sodium bicarbonate
Gastric Acid
Tadalafil
Erectile Dysfunction
Acarbose (Glucobay, BAYG5421)
Diabetes Mellitus
Darolutamide (BAY1841788, Nubeqa)
Biochemically Recurrent Prostate Cancer
Gynodian® Depot (BAY86-5032)
Hormone Replacement Therapy
Menostar (Estradiol, BAY86-5435)
Osteopenia
Gestodene/EE (FC Patch Low, BAY86-5016)
Contraception
DRSP 3 mg/EE 20 µg (13 cycles)
Dysmenorrhea
Carboplatin/Paclitaxel
Melanoma
Estradiol valerate/Dienogest (Natazia, Qlaira, BAY86-5027)
Metrorrhagia
Regorafenib (Stivarga, BAY73-4506)
Colorectal Neoplasms
EE20/DRSP(YAZ, BAY86-5300)
Premenstrual Dysphoric Disorder ( PMDD)
Acetylsalicylic acid (Aspirin, BAYE4465) & Lidocain
Common Cold
0.5mg DRSP / 0.5mg E2 (BAY86-4891)
Vasomotor Symptoms
Aflibercept (EYLEA, BAY86-5321)
Glaucoma, Neovascular
Aflibercept High Dose VEGF Trap-Eye (BAY86-5321)
Neovascular Age-Related Macular Degeneration
Levonorgestrel (BAY98-7196)
Contraception
Copanlisib (Aliqopa, BAY80-6946)
Lymphoma,Non-Hodgkin
Acetylsalicylic Acid (Aspirin, BAYE4465)
Common Cold
Dienogest (Visanne, BAY86-5258)
Endometriosis
Asundexian (BAY2433334)
Prevention of Ischemic Stroke
Tedizolid Phosphate (Sivextro, BAY1192631)
Skin Diseases, Infectious
EE20/Drospirenone (YAZ, BAY86-5300)
Acne Vulgaris
Vardenafil ODT (STAXYN, BAY38-9456)
Erectile Dysfunction
Ertapenem intravenous
Infection
Riociguat (Adempas, BAY63-2521)
Hypertension, Pulmonary
Ofloxacin
Pelvic Inflammatory Disease
EV/DNG (Qlaira, BAY86-5027)
Oral Contraceptive
Recombinant Factor VIII (Kogenate FS, BAY14-2222)
Hemophilia A
Phenylephrine
Seasonal Allergic Rhinitis
LNG IUS
Menopause
Best standard of care (BSoC)
Hormone Refractory Prostate Cancer
Gadobutrol (Gadovist, Gadavist, BAY86-4875)
Coronary Artery Disease
Naproxen sodium and caffeine (BAY2880376)
Postoperative Dental Pain
BAY 59-7939
Pulmonary Embolism
Sulbactam/Ampicillin
Pneumonia, Aspiration
Radium-223 dichloride (Xofigo, BAY88-8223)
Prostatic Neoplasms
rFVIII (BAY81-8973) on demand
Hemophilia A
Levonorgestrel IUS (Mirena, BAY86-5028)
Menorrhagia
Aflibercept (Eylea, BAY 86-5321)
Glaucoma, Neovascular
Butenafine HCl 1% (BAY1896425)
Hypersensitivity
Visudyne
Macular Degeneration
Naproxen Sodium IR (Aleve, BAYH6689)
Pain, Postoperative
Vardenafil (Levitra, BAY38-9456)
Prostatic Hypertrophy, Benign
Regorafenib (BAY73-4506)
Colorectal Neoplasms
Phenylephrine Hydrochloride (HCl) Extended-Release tablets 30 mg
Blood Pressure
Vasovist (BAY86-5283, MS-325)
Peripheral Vascular Diseases
BAY86-5016, SH P00331F
Contraception
Recombinant Factor VIII (BAY81-8973)
Blood Coagulation Disorders
BAY3723113
Obstructive Hypertrophic Cardiomyopathy
BAY2927088
Advanced Solid Tumors
Trasylol (Aprotinin, BAYA0128)
Blood Loss, Surgical
Visanne (BAY86-5258, SH T00660AA)
Endometriosis
Interferon beta-1b (Betaferon/Betaseron, BAY86-5046)
Multiple Sclerosis, Relapsing-Remitting
Drospirenone/Ethinylestradiol/Methyltetrahydrofolate
Neural Tube Defects
Levonorgestrel IUD (LCS, BAY86-5028)
Contraception
Bifonazole cream 1%
Onychomycosis
Valette
Acne Vulgaris
BAY1841788 / darolutamide (ODM-201)
Metastatic Hormone-sensitive Prostate Cancer
Medroxyprogesterone acetate
Endometrial Hyperplasia
Nifedipine (Adalat, BAYA1040)
Hypertension
Lanthanum Carbonate (BAY77-1931)
Hyperphosphatemia
Levonorgestrel IUS (LCS, BAY86-5028)
Contraception
LCS12
Contraception
Yasmin (30 µg EE, 3 mg Drospirenone, BAY86-5131)
Healthy
Butenafine HCl 1% (BAY1896425) - Induction Phase
Dermatitis, Photoallergic
Ethinylestradiol/Gestodene (BAY86-5016)
Contraception
Testosterone undecanoate (TU) - NebidoTM
Hypogonadism
Aspirin (Acetylsalicylic acid, BAYE4465)
Moderate Risk of CVD
Riociguat (BAY63-2521)
Hypertension, Pulmonary
Yasmin 20
Contraception
Iopromide 370 mg I/mL
Computed Tomography
Best supportive care
Gastrointestinal Stromal Tumors
Positive Control-Sodium lauryl sulfate (SLS)
Hypersensitivity
Ortho Tri Cyclen Lo
Contraception
Advil
Pain
Iloprost (Ventavis inhaled, BAYQ6256)
Hypertension, Pulmonary
Gadopentetate dimeglumine (Magnevist, BAY86-6661)
Magnetic Resonance Imaging
STW5 (Iberogast, BAY98-7411)
Irritable Bowel Syndrome
Phenylephrine HCl (Sinus Comfort, BAY112476)
Nasal Congestion Due to Allergic Rhinitis
Flexible (extended) treatment of EE20/DRSP (YAZ, BAY86-5300)
Contraception
Kogenate (BAY14-2222)
Hemophilia
EE20/DRSP (BAY86-5300)
Contraception
Vitamin K antagonist (VKA)
Atrial Fibrillation
Phenylephrine Hydrochloride (HCl) Extended Release (ER) Tablets 30 mg
Vasomotor Rhinitis
Levofloxacin + Ceftriaxone
Pneumonia
8 mg aflibercept (BAY 86-5321) (High Dose)
Diabetic Macular Edema
Gestodene/EE Patch (BAY86-5016)
Contraception
SH T04740B
Dysmenorrhea
Naproxen Sodium 440 mg / DPH 25 mg (BAY98-7111)
Pain, Postoperative
Visanne (SH T00660AA , BAY86-5258)
Endometriosis
EV/DNG (Qlaira, BAY86-5027, SH T00658K)
Contraception
Menostar (estradiol transdermal delivery system)
Hot Flashes
Aflibercept Injection (EYLEA, VEGF Trap-Eye, BAY86-5321)
Retinal Vein Occlusion
Fosrenol (Lanthanum Carbonate, BAY77-1931)
Hyperphosphatemia
Azelastine hydrochloride (BAYR9258)
Allergic Rhinitis
Levonorgestrel (Kyleena, BAY86-5028)
Contraception
EE20/DRSP/L-5-MTHF (Beyaz, BAY98-7071)
Contraception
Valette (Dienogest/EE30, BAY86-5038)
Oral Contraceptive
BAY86-5300
Contraception
Ertapenem
Intraabdominal Infections
Naproxen sodium 440 mg/DPH 50 mg (BAY98-7111)
Pain
cefepime
Febrile Neutropenia
Rivaroxaban
Symptomatic Superficial Vein Thrombosis
Finerenone 20 MG Oral Tablet
Type2diabetes
Rivaroxaban (20 mg)
Rheumatic Heart Disease
drospirenone and ethinyl estradiol
Acne Vulgaris
Rivaroxaban, 10 mg
Heart Failure
0.5mg NETA / 1.0mg E2 (Activella)
Postmenopause
Copanlisib (BAY 80-6946)
Lymphoma, Non-Hodgkin
Enoxaparin overlapping with and followed by VKA
Pulmonary Embolism
Calcium carbonate
Hyperphosphatemia
Sorafenib
Ovarian Cancer
Moxifloxacin/Metronidazole or Piperacillin/Tazobactam
Abscess, Intra-Abdominal
Deoxycholic acid injection
Moderate or Severe Submental Fullness
Standard ADT (androgen deprivation therapy)
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Losartan
COVID-19 Associated Cardiac Involvement
Acyclovir 50mg buccal/topical tablet, BAYM008894/UI1614773
Recurrent Herpes Labialis
Aficamten
Pediatric
Azelaic Acid Gel 15% (Finacea, BAY39-6251)
Acne Vulgaris
Rivaroxaban 10 mg qd
Atrial Fibrillation
Acetylsalicylic acid
Aortic Valve Stenosis
Pantoprazole
Prevention & Control
emodepside (BAY 44-4400)
Trichuris Trichiura; Infection
colecalciferol
Multiple Sclerosis
Testosterone gel
Erectile Dysfunction
Rivaroxaban 2.5 Mg Oral Tablet
Chronic Kidney Diseases
D,L-lysine acetylsalicylate (Aspirin, BAY81-8781) 500 mg IV
Acute Coronary Syndrome
Regorafenib (Stivarga, BAY73- 4506)
Colorectal Neoplasms
EE20/DRSP (YAZ, BAY86-5300)
Oral Contraceptive
Acetylsalicylic Acid (Aspirin Complex, BAYE4465) + Pseudoephedrine
Common Cold
Acetylsalicyclic acid (Fast acting Aspirin, BAY1019036)
Drugs, Investigational
Gadoquatrane (BAY1747846)
Contrast Enhancement in Magnetic Resonance Imaging
Laif® 900, BAY98-7108
Moderate Depressive Episodes (Major Depression)
omeprazole magnesium (20 mg equivalent)
Gastric Acid
Naproxen Sodium ER (BAYH6689)
Pain
Gadobutrol
Contrast Enhancement in Magnetic Resonance Imaging
Standard of Care
Venous Thromboembolism
Zevalin ([90]Y-ibritumomab tiuxetan, BAY86-5128)
Lymphoma, Non-Hodgkin
Estradiol/DRSP (Angeliq, BAY86-4891)
Vasomotor Symptoms
Zegerid
Intragastric Acidity
Acetylsalicylic acid (Fast release Aspirin, BAY1019036)
Drugs, Investigational
Magnevist (SH L 451A)
Brain Neoplasms
Interferon beta-1b (Betaseron, BAY86-5046)
Multiple Sclerosis
Magnevist
Central Nervous System Diseases
Moxifloxacin (Avelox, BAY12-8039)
Abscess
Naproxen sodium 440 mg / DPH 50 mg (BAY98-7111)
Pain, Postoperative
YAZ (SH T00186, BAY86-5300)
Contraception
Darolutamide (Nubeqa, BAY1841788)
Prostatic Neoplasms
Ranibizumab
Macular Degeneration
Nifurtimox (Lampit, BAYA2502)
Chagas Disease
ProHance
Brain Metastases
Prevacid®
Human Experimentation
SH D 593 B (Miranova)
Contraception
Ethinylestradiol/Gestodene (FC Patch Low BAY86-5016)
Contraception
Acarbose
Diabetes Mellitus, Type 2
alemtuzumab
Leukemia
Sunscreen Test Code: V53-028
Sun Protection
Eylea (Aflibercept, BAY86-5321)
Retinopathy of Prematurity (ROP)
Drug: YAZ flex (SH T00186D)
Primary Dysmenorrhea
Gadobutrol (Gadovist, BAY86-4875)
Magnetic Resonance Imaging
Finerenone (BAY94-8862)
Chronic Kidney Disease
Sorafenib (Nexavar, BAY43-9006)
Carcinoma, Renal Cell
Yasmin
Contraception
Nexavar (Sorafenib, BAY43-9006)
Carcinoma, Renal Cell
Interferon beta-1b
HIV Infections
BAY94-9027
Hemophilia A
Rivaroxaban (BAY59-7939)
Venous Thromboembolism
Aflibercept, VEGF Trap-Eye(Eylea, BAY86-5321)_higher dose
Macular Edema Secondary to Retinal Vein Occlusion
Gadopentetate dimeglumine (Magnevist)
Cardiovascular Abnormalities
Darbepoetin
Anemia
Naproxen gel
Soft Tissue Injury
Amikacin (BAY41-6551)
Pneumonia
BAY94-8862
Diabetic Nephropathies
Zevalin (SH L 749 , BAY86-5128)
Non-Hodgkin's Lymphoma
BAY 3401016
Alport Syndrome
Vericiguat (BAY1021189) 2.5 mg, 5 mg or 10 mg IR tablets
Chronic Heart Failure With Preserved Ejection Fraction
Enoxaparin/Vitamin K-Antagonist
Venous Thrombosis
RDEA119
Advanced Cancer
BAY86-4891 (Estradiol / Drospirenone)
Contraception
Runcaciguat (BAY1101042)
Diabetic Retinopathy
Vilaprisan (BAY1002670)
Leiomyoma
Yasminelle (SH T 00186 D)
Contraceptives, Oral
Gadobutrol~0.03 mmol/kg BW (Gadavist, Gadovist, BAY86-4875)
Brain Diseases
Gadobutrol (Gadavist,Gadovist, BAY86-4875)
Myocardial Perfusion Imaging
BAY 1753011
Heart Failure (HF)
BAY2586116
Sleep Apnea, Obstructive
Epoetin alfa/beta
Anemia
Taxane (Cytotoxic, BAY59-8862)
Lymphoma, Non-Hodgkin
Nexavar (Sorafenib)
Breast Cancer
Naproxen sodium/Caffeine (BAY2880376)
Pain, Postoperative
Molidustat (BAY 85-3934)
Anemia
Sagopilone (BAY86-5302, ZK 219477)
Breast Neoplasms
Adempas
Chronic Thromboembolic Disease (CTED)
Drospirenone/17ß-estradiol (Angeliq, BAY86-4891)
Postmenopause
CHOP regimen alternate with ESHAP regimen
Peripheral T-cell Lymphoma
BAY2927088_formulation A
Advanced Non-small Cell Lung Cancer
Combination drug
Cancer
BAY3427080
Post-menopausal Vasomotor Symptoms
BAY85-8501
Bronchiectasis
Asoprisnil (BAY86-5294)
Menorrhagia
Sorafenib and Gemcitabine
Carcinoma, Hepatocellular
SH T04769G
Oral Contraceptive
Darolutamide
High-Risk Localized Prostate Cancer
Rivaroxaban 10 MG Oral Tablet [Xarelto]
Bariatric Surgery
Eplerenone
Heart Failure
Sagopilone (ZK 219477) + prednisone
Prostate Cancer
Campath-1H
Lymphoplasmacytic Lymphoma
Sorafenib (Nexavar, BAY43-9006) plus Doxorubicin
Carcinoma, Hepatocellular
BAY1002670
Leiomyoma
BAY3283142
Chronic Kidney Disease
Epirubicin Hydrochloride
Pleomorphic Rhabdomyosarcoma
Sorafenib Plus Capecitabine (SorCape)
Colorectal Cancer Metastatic
Larotrectinib (Vitrakvi, BAY2757556)
Solid Tumors Harboring NTRK Fusion
Sorafenib (BAY43-9006)
Carcinoma, Hepatocellular
BAY86-9766 MEK Inhibitor + Sorafenib
Carcinoma, Hepatocellular
BAY86-9766+Gemcitabine
Pancreatic Neoplasms
BAY1902607
Cough
Magnevist (Gadopentetate dimeglumine, BAY86-4882)
Myocardial Infarction
Spironolactone
Heart Failure
STW5 (Iberogast®, BAY98-7411)
Functional Gastrointestinal Disorders
Gadobutrol (Gadovist/Gadavist)
Central Nervous System Pathology
BAY1067197 (10 mg)
Heart Failure
Zabedosertib (BAY1834845)
Atopic Dermatitis
Piroxicam ( BAYl1902)
Contraception, Postcoital
ZK245186
Atopic Dermatitis
Sorafenib (Nexavar, BAY43-9006) + mFOLFOX6 (5-FU, levo-leucovorin, oxaliplatin)
Metastatic Colorectal Cancer
CS1001
Advanced Refractory Solid Tumors
Interferon beta 1b (Betaseron, BAY86-5046)
Multiple Sclerosis, Relapsing-Remitting
Capadenoson (BAY68-4986)
Atrial Fibrillation
BAY3018250
Thrombolysis
Xarelto (Rivaroxaban, BAY59-7939)
Atrial Fibrillation
Lonaprisan (ZK 230211, BAY86-5044)
Metastatic Breast Cancer
CCR1-Antagonist (BAY86-5047, ZK811752)
Endometriosis
Sorafenib (Nexavar,BAY43-9006)
Thyroid Carcinoma
BAY2433334
Atrial Fibrillation (AF)
Darolutamide 600 mg twice daily
Prostate Cancer
BAY98-7443
Contraception
Fesomersen sodium (BAY2976217)
End Stage Renal Disease Requiring Hemodialysis
Sorafenib (Nexavar, BAY43-9006) + Dacarbazine (DTIC)
Melanoma
Histone Deacetylase Inhibitor, MS-275 (BAY 86-5274, ZK 244894)
Melanoma
SH D01155E
Pregnancy, Unplanned
Fulacimstat (BAY1142524)
Myocardial Infarction
Concurrent use of Radium Ra 223 dichloride and Abiraterone Acetate plus Prednisone
Prostate Cancer
BAY1193397
Diabetic Foot
BAY2586116 (A1)
Sleep Apnea, Obstructive
Nivolumab (Opdivo)
Colorectal Cancer
lloprost(Ventavis,BAYQ6252, 20 µg/mL)
Pulmonary Arterial Hypertension
Inspra (eplerenone)
Heart Failure
Abiraterone acetate
Prostate Cancer
BAY 77-1931
Hyperphosphatemia
Levonorgestrel IUS (BAY86-5028, G04209B)
Contraception
BAY59-8862 (Cytotoxic Taxane)
Carcinoma, Non-Small-Cell Lung
Dehydroepiandrosterone, BAY86-5314
Libido
BAY1213790 (Osocimab)
End-stage Renal Disease
Non-active base from azelaic acid 15% gel
Perioral Dermatitis
Anetumab ravtansine (BAY94-9343)
Mesothelioma
BAY1067197 (treatment 2)
Heart Failure
Dexpanthenol foam spray, old formulation
Erythema
Gemcitabine
Pancreatic Cancer
BAY2253651
Sleep Apnea, Obstructive
Sagopilone (BAY86-5302 , ZK219477)
Ovarian Neoplasms
Hydrocortison cream
Atopic Dermatitis
Cisplatin
Renal Cell Carcinoma
BAY60-4552 plus Vardenafil
Erectile Dysfunction
Vericiguat (BAY1021189) (5 mg)
Heart Failure
BAY2395840
Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
Phenylephrine HCl
Rhinitis
Mapracorat
Atopic Dermatitis
Etoposide
Lymphoma
emodepside
Onchocerciasis
Levonorgestrel
Endometriosis
Riociguat
Scleroderma
Darolutamide(BAY1841788, Nubeqa)
Biochemically Recurrent Prostate Cancer
Ciprofloxacin (Cipro Inhale, BAYQ3939)
Cystic Fibrosis
Vardenafil HCl (Levitra, BAY38-9456)
Overactive Bladder
Regorafenib (BAY 73-4506)
Colorectal Cancer Metastatic
Oxymetazoline HCl 0.05% nasal gel
Nasal Congestion
Copanlisib (BAY80-6946)
Lymphoma Non-Hodgkin
Ethinylestradiol/Gestogene (BAY86-5016)
Contraception
Regorafenib, (Stivarga, BAY73-4506)
Solid Tumors
Sagopilone (ZK 219477) + carboplatin
Ovarian Neoplasms
Bay 59-8862
Carcinoma, Renal Cell
BAY2599023 (DTX201)
Hemophilia A
Sagopilone (ZK 219477)
Breast Neoplasm
Technetium Tc 99M Medronate
Castration-Resistant Prostate Carcinoma
runcaciguat
Chronic Kidney Disease
BAY73-4506 (Regorafenib, Stivarga)
Solid Cancer
E2/DRSP (BAY 86-4891) dose 1 (SH T04984E)
Contraceptive, Oral, Hormonal
BAY1817080
Overactive Bladder
Nifedipine (Adalat CR, BAYA1040) 80mg OD
Hypertension
EV/DNG (SH T00658L)
Ovulation Inhibition
BAY2757556 (Larotrectinib, Vitrakvi)
Solid Tumors Harboring NTRK Fusion
Vericiguat (BAY1021189) (1.25 mg)
Heart Failure
BAY73-4506
Carcinoma, Hepatocellular
UFH
Cardiovascular Disease
Vericiguat (BAY1021189) 5 mg
Chronic Heart Failure With Reduced Ejection Fraction
ZK 245186
Atopic Dermatitis
BAY 86-5310 (ZK 283197)
Vasomotor System
Active comparator
Venous Thrombosis
Refametinib (BAY86-9766)
Carcinoma, Hepatocellular
Repinotan HCl (BAYX3702)
Stroke
BAY1142524
Heart Failure
Neladenoson bialanate (BAY1067197)
Heart Failure
Radium-223 chloride (BAY88-8223)
Breast Cancer
Interferon
Carcinoma, Renal Cell
Capecitabine/Cisplatin + Sorafenib
Malignant Neoplasm of Stomach
ZK-EPO
Melanoma
Sagopilone 16 mg/m^2 i.v., Acetyl-L-Carnitine (ALC) 1000 mg tid, HRPC only: Prednisone or Prednisolone 5 mg bid
Prostate Cancer
Sargramostim (GM-CSF)
Lymphoma
SH T00268C
Non Small Cell Lung Cancer
Polyethylene Glycol (PEG 3350)
Constipation
Copanlisib
Marginal Zone Lymphoma
Finerenone (BAY94-8862 ) 10 mg
Type 2 Diabetes Mellitus
Radium-223
Prostate Cancer
sorafenib tosylate
Adult Primary Hepatocellular Carcinoma
Riociguat (Adempas, BAY63-2521).
Hypertension, Pulmonary
Bifonazole spray once daily
Tinea Pedis
Interferon-α-2b
Leukemia
Elinzanetant
Sleep Disturbances Associated With Menopause
Gadopentetate dimeglumine (Magnevist, BAY86-4882, SH L 451A)
Magnetic Resonance Angiography
Dexpanthenol foam spray, new formulation
Skin Abnormalities
Naproxen Sodium (Aleve, BAY117031)
Osteoarthritis, Knee
PEG 3350 laxative plus electrolytes (PEG + E)/Macrogol (Movicol®, BAY81-8430)
Constipation
chemotherapy followed by Zevalin
Diffuse Large B-cell Lymphoma
BAY 3713372
MTAP-deleted Solid Tumors
Vericiguat Oral Tablet
Post-COVID ME/CFS
(LMW) Heparin + Vitamin K Antagonist
Venous Thromboembolism
Betaseron (Interferon beta-1b, BAY86-5046)
Multiple Sclerosis
Rivaroxaban, (BAY59-7939)
Venous Thromboembolism
sorafenib, vorinostat and bortezomib
Acute Myeloid Leukemia
Interleukin-2 SA
HIV Infections
BAY85-3934
Anemia
Candesartan cilexetil (Atacand), 4 mg
Hypertension, Essential
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Low-molecular-weight heparin | Phase 3 | Neoplasm | - | - |
Finerenone (Kerendia, BAY94-8862) | Phase 3 | Chronic Kidney Disease | - | - |
Oxybutynin (Oxytrol, BAY839380) | Phase 3 | Overactive Bladder | - | - |
Amikacin Inhalation Solution (BAY41-6551) | Phase 3 | Pneumonia, Bacterial | - | - |
Gadopentetate dimeglumine (Magnevist, BAY86-4882) | Phase 3 | Peripheral Vascular Disease | - | - |
Ventavis (Iloprost, BAYQ6256) | Phase 3 | Hypertension, Pulmonary | - | - |
Rivaroxaban (Xarelto, BAY59-7939) | Phase 3 | Pulmonary Embolism | - | - |
Gadobutrol (Gadavist, Gadovist, BAY86-4875) | Phase 3 | Vascular Diseases | - | - |
EE20/DRSP(BAY86-5300) | Phase 3 | Endometriosis | - | - |
Acetylsalicyclic acid (Fast release Aspirin, BAY1019036) | Phase 3 | Healthy Subjects | - | - |
Elinzanetant (BAY3427080) | Phase 3 | Vasomotor Symptoms Associated With Menopause | - | - |
YAZ (DRSP 3 mg/EE 0.02 mg, BAY86-5300) | Phase 3 | Contraception | - | - |
Rogaratinib (BAY1163877) | Phase 3 | Carcinoma, Transitional Cell | - | - |
EV/DNG (Qlaira, BAY86-5027, SH T00658ID) | Phase 3 | Contraception | - | - |
Damoctocog alfa pegol (Jivi, BAY94-9027) | Phase 3 | Treatment of Bleeding | - | - |
Finerenone | Phase 3 | Chronic Kidney Disease | - | - |
Enoxaparin followed by VKA | Phase 3 | Venous Thrombosis | - | - |
Levitra (Vardenafil, BAY38-9456) | Phase 3 | Erectile Dysfunction | - | - |
Estradiol valerate, Dienogest (Natazia, Qlaira, BAY86-5027) | Phase 3 | Primary Dysmenorrhea | - | - |
EV/DNG (Qlaira, Natazia, BAY86-5027) | Phase 3 | Metrorrhagia | - | - |
Radium-223 dichloride (BAY88-8223) | Phase 3 | Prostatic Neoplasms | - | - |
Clotrimazole, vaginal ovule | Phase 3 | Clotrimazole | - | - |
LNG-IUS (BAY 86-5028) | Phase 3 | Contraception | - | - |
Gadoteridol (ProHance) | Phase 3 | Diagnostic Imaging | - | - |
Unfractionated heparin | Phase 3 | Deep Vein Thrombosis | - | - |
Nifedipine GITS/Candesartan Cilexetil FDC(BAY98-7106) | Phase 3 | Hypertension | - | - |
Recombinant Factor VIII (Kovaltry, BAY81-8973) | Phase 3 | Haemophilia A | - | - |
Tedizolid (BAY119-2631) | Phase 3 | Bacterial Infections | - | - |
Skyla (Levonorgestrel, BAY86-5028) | Phase 3 | Contraception | - | - |
Avelox (Moxifloxacin, BAY12-8039) | Phase 3 | Infectious Diseases | - | - |
BAY86-6150 | Phase 3 | Hemophilia A, Hemophilia B | - | - |
Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321) | Phase 3 | Macular Edema | - | - |
VEGF Trap-Eye (BAY86-5321) | Phase 3 | Myopia, Pathological | - | - |
Molidustat (BAY85-3934) | Phase 3 | Anemia | - | - |
Angeliq (Drospirenone/17ß-estradiol, BAY86-4891) | Phase 3 | Vasomotor Symptoms | - | - |
Gadoxetic Acid Disodium (Primovist, BAY86-4873) | Phase 3 | Known or Suspected Focal Liver Lesions | - | - |
Darbepoetin alfa | Phase 3 | Anemia | - | - |
Testogel (Testosterone, BAYV001915) | Phase 3 | Androgens (Deficiency) | - | - |
Minisiston (SH D00342A) | Phase 3 | Contraception | - | - |
Gadoterate meglumine | Phase 3 | Contrast Enhancement in Magnetic Resonance Imaging | - | - |
Omeprazole/sodium bicarbonate | Phase 3 | Gastric Acid | - | - |
Tadalafil | Phase 3 | Erectile Dysfunction | - | - |
Acarbose (Glucobay, BAYG5421) | Phase 3 | Diabetes Mellitus | - | - |
Darolutamide (BAY1841788, Nubeqa) | Phase 3 | Biochemically Recurrent Prostate Cancer | - | - |
Gynodian® Depot (BAY86-5032) | Phase 3 | Hormone Replacement Therapy | - | - |
Menostar (Estradiol, BAY86-5435) | Phase 3 | Osteopenia | - | - |
Gestodene/EE (FC Patch Low, BAY86-5016) | Phase 3 | Contraception | - | - |
DRSP 3 mg/EE 20 µg (13 cycles) | Phase 3 | Dysmenorrhea | - | - |
Carboplatin/Paclitaxel | Phase 3 | Melanoma | - | - |
Estradiol valerate/Dienogest (Natazia, Qlaira, BAY86-5027) | Phase 3 | Metrorrhagia | - | - |
Regorafenib (Stivarga, BAY73-4506) | Phase 3 | Colorectal Neoplasms | - | - |
EE20/DRSP(YAZ, BAY86-5300) | Phase 3 | Premenstrual Dysphoric Disorder ( PMDD) | - | - |
Acetylsalicylic acid (Aspirin, BAYE4465) & Lidocain | Phase 3 | Common Cold | - | - |
0.5mg DRSP / 0.5mg E2 (BAY86-4891) | Phase 3 | Vasomotor Symptoms | - | - |
Aflibercept (EYLEA, BAY86-5321) | Phase 3 | Glaucoma, Neovascular | - | - |
Aflibercept High Dose VEGF Trap-Eye (BAY86-5321) | Phase 3 | Neovascular Age-Related Macular Degeneration | - | - |
Levonorgestrel (BAY98-7196) | Phase 3 | Contraception | - | - |
Copanlisib (Aliqopa, BAY80-6946) | Phase 3 | Lymphoma,Non-Hodgkin | - | - |
Acetylsalicylic Acid (Aspirin, BAYE4465) | Phase 3 | Common Cold | - | - |
Dienogest (Visanne, BAY86-5258) | Phase 3 | Endometriosis | - | - |
Asundexian (BAY2433334) | Phase 3 | Prevention of Ischemic Stroke | - | - |
Tedizolid Phosphate (Sivextro, BAY1192631) | Phase 3 | Skin Diseases, Infectious | - | - |
EE20/Drospirenone (YAZ, BAY86-5300) | Phase 3 | Acne Vulgaris | - | - |
Vardenafil ODT (STAXYN, BAY38-9456) | Phase 3 | Erectile Dysfunction | - | - |
Ertapenem intravenous | Phase 3 | Infection | - | - |
Riociguat (Adempas, BAY63-2521) | Phase 3 | Hypertension, Pulmonary | - | - |
Ofloxacin | Phase 3 | Pelvic Inflammatory Disease | - | - |
EV/DNG (Qlaira, BAY86-5027) | Phase 3 | Oral Contraceptive | - | - |
Recombinant Factor VIII (Kogenate FS, BAY14-2222) | Phase 3 | Hemophilia A | - | - |
Phenylephrine | Phase 3 | Seasonal Allergic Rhinitis | - | - |
LNG IUS | Phase 3 | Menopause | - | - |
Best standard of care (BSoC) | Phase 3 | Hormone Refractory Prostate Cancer | - | - |
Gadobutrol (Gadovist, Gadavist, BAY86-4875) | Phase 3 | Coronary Artery Disease | - | - |
Naproxen sodium and caffeine (BAY2880376) | Phase 3 | Postoperative Dental Pain | - | - |
BAY 59-7939 | Phase 3 | Pulmonary Embolism | - | - |
Sulbactam/Ampicillin | Phase 3 | Pneumonia, Aspiration | - | - |
Radium-223 dichloride (Xofigo, BAY88-8223) | Phase 3 | Prostatic Neoplasms | - | - |
rFVIII (BAY81-8973) on demand | Phase 3 | Hemophilia A | - | - |
Levonorgestrel IUS (Mirena, BAY86-5028) | Phase 3 | Menorrhagia | - | - |
Aflibercept (Eylea, BAY 86-5321) | Phase 3 | Glaucoma, Neovascular | - | - |
Butenafine HCl 1% (BAY1896425) | Phase 3 | Hypersensitivity | - | - |
Visudyne | Phase 3 | Macular Degeneration | - | - |
Naproxen Sodium IR (Aleve, BAYH6689) | Phase 3 | Pain, Postoperative | - | - |
Vardenafil (Levitra, BAY38-9456) | Phase 3 | Prostatic Hypertrophy, Benign | - | - |
Regorafenib (BAY73-4506) | Phase 3 | Colorectal Neoplasms | - | - |
Phenylephrine Hydrochloride (HCl) Extended-Release tablets 30 mg | Phase 3 | Blood Pressure | - | - |
Vasovist (BAY86-5283, MS-325) | Phase 3 | Peripheral Vascular Diseases | - | - |
BAY86-5016, SH P00331F | Phase 3 | Contraception | - | - |
Recombinant Factor VIII (BAY81-8973) | Phase 3 | Blood Coagulation Disorders | - | - |
BAY3723113 | Phase 3 | Obstructive Hypertrophic Cardiomyopathy | - | - |
BAY2927088 | Phase 3 | Advanced Solid Tumors | - | - |
Trasylol (Aprotinin, BAYA0128) | Phase 3 | Blood Loss, Surgical | - | - |
Visanne (BAY86-5258, SH T00660AA) | Phase 3 | Endometriosis | - | - |
Interferon beta-1b (Betaferon/Betaseron, BAY86-5046) | Phase 3 | Multiple Sclerosis, Relapsing-Remitting | - | - |
Drospirenone/Ethinylestradiol/Methyltetrahydrofolate | Phase 3 | Neural Tube Defects | - | - |
Levonorgestrel IUD (LCS, BAY86-5028) | Phase 3 | Contraception | - | - |
Bifonazole cream 1% | Phase 3 | Onychomycosis | - | - |
Valette | Phase 3 | Acne Vulgaris | - | - |
BAY1841788 / darolutamide (ODM-201) | Phase 3 | Metastatic Hormone-sensitive Prostate Cancer | - | - |
Medroxyprogesterone acetate | Phase 3 | Endometrial Hyperplasia | - | - |
Nifedipine (Adalat, BAYA1040) | Phase 3 | Hypertension | - | - |
Lanthanum Carbonate (BAY77-1931) | Phase 3 | Hyperphosphatemia | - | - |
Levonorgestrel IUS (LCS, BAY86-5028) | Phase 3 | Contraception | - | - |
LCS12 | Phase 3 | Contraception | - | - |
Yasmin (30 µg EE, 3 mg Drospirenone, BAY86-5131) | Phase 3 | Healthy | - | - |
Butenafine HCl 1% (BAY1896425) - Induction Phase | Phase 3 | Dermatitis, Photoallergic | - | - |
Ethinylestradiol/Gestodene (BAY86-5016) | Phase 3 | Contraception | - | - |
Testosterone undecanoate (TU) - NebidoTM | Phase 3 | Hypogonadism | - | - |
Aspirin (Acetylsalicylic acid, BAYE4465) | Phase 3 | Moderate Risk of CVD | - | - |
Riociguat (BAY63-2521) | Phase 3 | Hypertension, Pulmonary | - | - |
Yasmin 20 | Phase 3 | Contraception | - | - |
Iopromide 370 mg I/mL | Phase 3 | Computed Tomography | - | - |
Best supportive care | Phase 3 | Gastrointestinal Stromal Tumors | - | - |
Positive Control-Sodium lauryl sulfate (SLS) | Phase 3 | Hypersensitivity | - | - |
Ortho Tri Cyclen Lo | Phase 3 | Contraception | - | - |
Advil | Phase 3 | Pain | - | - |
Iloprost (Ventavis inhaled, BAYQ6256) | Phase 3 | Hypertension, Pulmonary | - | - |
Gadopentetate dimeglumine (Magnevist, BAY86-6661) | Phase 3 | Magnetic Resonance Imaging | - | - |
STW5 (Iberogast, BAY98-7411) | Phase 3 | Irritable Bowel Syndrome | - | - |
Phenylephrine HCl (Sinus Comfort, BAY112476) | Phase 3 | Nasal Congestion Due to Allergic Rhinitis | - | - |
Flexible (extended) treatment of EE20/DRSP (YAZ, BAY86-5300) | Phase 3 | Contraception | - | - |
Kogenate (BAY14-2222) | Phase 3 | Hemophilia | - | - |
EE20/DRSP (BAY86-5300) | Phase 3 | Contraception | - | - |
Vitamin K antagonist (VKA) | Phase 3 | Atrial Fibrillation | - | - |
Phenylephrine Hydrochloride (HCl) Extended Release (ER) Tablets 30 mg | Phase 3 | Vasomotor Rhinitis | - | - |
Levofloxacin + Ceftriaxone | Phase 3 | Pneumonia | - | - |
8 mg aflibercept (BAY 86-5321) (High Dose) | Phase 3 | Diabetic Macular Edema | - | - |
Gestodene/EE Patch (BAY86-5016) | Phase 3 | Contraception | - | - |
SH T04740B | Phase 3 | Dysmenorrhea | - | - |
Naproxen Sodium 440 mg / DPH 25 mg (BAY98-7111) | Phase 3 | Pain, Postoperative | - | - |
Visanne (SH T00660AA , BAY86-5258) | Phase 3 | Endometriosis | - | - |
EV/DNG (Qlaira, BAY86-5027, SH T00658K) | Phase 3 | Contraception | - | - |
Menostar (estradiol transdermal delivery system) | Phase 3 | Hot Flashes | - | - |
Aflibercept Injection (EYLEA, VEGF Trap-Eye, BAY86-5321) | Phase 3 | Retinal Vein Occlusion | - | - |
Fosrenol (Lanthanum Carbonate, BAY77-1931) | Phase 3 | Hyperphosphatemia | - | - |
Azelastine hydrochloride (BAYR9258) | Phase 3 | Allergic Rhinitis | - | - |
Levonorgestrel (Kyleena, BAY86-5028) | Phase 3 | Contraception | - | - |
EE20/DRSP/L-5-MTHF (Beyaz, BAY98-7071) | Phase 3 | Contraception | - | - |
Valette (Dienogest/EE30, BAY86-5038) | Phase 3 | Oral Contraceptive | - | - |
BAY86-5300 | Phase 3 | Contraception | - | - |
Ertapenem | Phase 3 | Intraabdominal Infections | - | - |
Naproxen sodium 440 mg/DPH 50 mg (BAY98-7111) | Phase 3 | Pain | - | - |
cefepime | Phase 3 | Febrile Neutropenia | - | - |
Rivaroxaban | Phase 3 | Symptomatic Superficial Vein Thrombosis | - | - |
Finerenone 20 MG Oral Tablet | Phase 3 | Type2diabetes | - | - |
Rivaroxaban (20 mg) | Phase 3 | Rheumatic Heart Disease | - | - |
drospirenone and ethinyl estradiol | Phase 3 | Acne Vulgaris | - | - |
Rivaroxaban, 10 mg | Phase 3 | Heart Failure | - | - |
0.5mg NETA / 1.0mg E2 (Activella) | Phase 3 | Postmenopause | - | - |
Copanlisib (BAY 80-6946) | Phase 3 | Lymphoma, Non-Hodgkin | - | - |
Enoxaparin overlapping with and followed by VKA | Phase 3 | Pulmonary Embolism | - | - |
Calcium carbonate | Phase 3 | Hyperphosphatemia | - | - |
Sorafenib | Phase 3 | Ovarian Cancer | - | - |
Moxifloxacin/Metronidazole or Piperacillin/Tazobactam | Phase 3 | Abscess, Intra-Abdominal | - | - |
Deoxycholic acid injection | Phase 3 | Moderate or Severe Submental Fullness | - | - |
Standard ADT (androgen deprivation therapy) | Phase 3 | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) | - | - |
Losartan | Phase 3 | COVID-19 Associated Cardiac Involvement | - | - |
Acyclovir 50mg buccal/topical tablet, BAYM008894/UI1614773 | Phase 3 | Recurrent Herpes Labialis | - | - |
Aficamten | Phase 3 | Pediatric | - | - |
Azelaic Acid Gel 15% (Finacea, BAY39-6251) | Phase 3 | Acne Vulgaris | - | - |
Rivaroxaban 10 mg qd | Phase 3 | Atrial Fibrillation | - | - |
Acetylsalicylic acid | Phase 3 | Aortic Valve Stenosis | - | - |
Pantoprazole | Phase 3 | Prevention & Control | - | - |
emodepside (BAY 44-4400) | Phase 3 | Trichuris Trichiura; Infection | - | - |
colecalciferol | Phase 3 | Multiple Sclerosis | - | - |
Testosterone gel | Phase 3 | Erectile Dysfunction | - | - |
Rivaroxaban 2.5 Mg Oral Tablet | Phase 3 | Chronic Kidney Diseases | - | - |
D,L-lysine acetylsalicylate (Aspirin, BAY81-8781) 500 mg IV | Phase 3 | Acute Coronary Syndrome | - | - |
Regorafenib (Stivarga, BAY73- 4506) | Phase 3 | Colorectal Neoplasms | - | - |
EE20/DRSP (YAZ, BAY86-5300) | Phase 3 | Oral Contraceptive | - | - |
Acetylsalicylic Acid (Aspirin Complex, BAYE4465) + Pseudoephedrine | Phase 3 | Common Cold | - | - |
Acetylsalicyclic acid (Fast acting Aspirin, BAY1019036) | Phase 3 | Drugs, Investigational | - | - |
Gadoquatrane (BAY1747846) | Phase 3 | Contrast Enhancement in Magnetic Resonance Imaging | - | - |
Laif® 900, BAY98-7108 | Phase 3 | Moderate Depressive Episodes (Major Depression) | - | - |
omeprazole magnesium (20 mg equivalent) | Phase 3 | Gastric Acid | - | - |
Naproxen Sodium ER (BAYH6689) | Phase 3 | Pain | - | - |
Gadobutrol | Phase 3 | Contrast Enhancement in Magnetic Resonance Imaging | - | - |
Standard of Care | Phase 3 | Venous Thromboembolism | - | - |
Zevalin ([90]Y-ibritumomab tiuxetan, BAY86-5128) | Phase 3 | Lymphoma, Non-Hodgkin | - | - |
Estradiol/DRSP (Angeliq, BAY86-4891) | Phase 3 | Vasomotor Symptoms | - | - |
Zegerid | Phase 3 | Intragastric Acidity | - | - |
Acetylsalicylic acid (Fast release Aspirin, BAY1019036) | Phase 3 | Drugs, Investigational | - | - |
Magnevist (SH L 451A) | Phase 3 | Brain Neoplasms | - | - |
Interferon beta-1b (Betaseron, BAY86-5046) | Phase 3 | Multiple Sclerosis | - | - |
Magnevist | Phase 3 | Central Nervous System Diseases | - | - |
Moxifloxacin (Avelox, BAY12-8039) | Phase 3 | Abscess | - | - |
Naproxen sodium 440 mg / DPH 50 mg (BAY98-7111) | Phase 3 | Pain, Postoperative | - | - |
YAZ (SH T00186, BAY86-5300) | Phase 3 | Contraception | - | - |
Darolutamide (Nubeqa, BAY1841788) | Phase 3 | Prostatic Neoplasms | - | - |
Ranibizumab | Phase 3 | Macular Degeneration | - | - |
Nifurtimox (Lampit, BAYA2502) | Phase 3 | Chagas Disease | - | - |
ProHance | Phase 3 | Brain Metastases | - | - |
Prevacid® | Phase 3 | Human Experimentation | - | - |
SH D 593 B (Miranova) | Phase 3 | Contraception | - | - |
Ethinylestradiol/Gestodene (FC Patch Low BAY86-5016) | Phase 3 | Contraception | - | - |
Acarbose | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
alemtuzumab | Phase 3 | Leukemia | - | - |
Sunscreen Test Code: V53-028 | Phase 3 | Sun Protection | - | - |
Eylea (Aflibercept, BAY86-5321) | Phase 3 | Retinopathy of Prematurity (ROP) | - | - |
Drug: YAZ flex (SH T00186D) | Phase 3 | Primary Dysmenorrhea | - | - |
Gadobutrol (Gadovist, BAY86-4875) | Phase 3 | Magnetic Resonance Imaging | - | - |
Finerenone (BAY94-8862) | Phase 3 | Chronic Kidney Disease | - | - |
Sorafenib (Nexavar, BAY43-9006) | Phase 3 | Carcinoma, Renal Cell | - | - |
Yasmin | Phase 3 | Contraception | - | - |
Nexavar (Sorafenib, BAY43-9006) | Phase 3 | Carcinoma, Renal Cell | - | - |
Interferon beta-1b | Phase 3 | HIV Infections | - | - |
BAY94-9027 | Phase 3 | Hemophilia A | - | - |
Rivaroxaban (BAY59-7939) | Phase 3 | Venous Thromboembolism | - | - |
Aflibercept, VEGF Trap-Eye(Eylea, BAY86-5321)_higher dose | Phase 3 | Macular Edema Secondary to Retinal Vein Occlusion | - | - |
Gadopentetate dimeglumine (Magnevist) | Phase 3 | Cardiovascular Abnormalities | - | - |
Darbepoetin | Phase 2 | Anemia | - | - |
Naproxen gel | Phase 2 | Soft Tissue Injury | - | - |
Amikacin (BAY41-6551) | Phase 2 | Pneumonia | - | - |
BAY94-8862 | Phase 2 | Diabetic Nephropathies | - | - |
Zevalin (SH L 749 , BAY86-5128) | Phase 2 | Non-Hodgkin's Lymphoma | - | - |
BAY 3401016 | Phase 2 | Alport Syndrome | - | - |
Vericiguat (BAY1021189) 2.5 mg, 5 mg or 10 mg IR tablets | Phase 2 | Chronic Heart Failure With Preserved Ejection Fraction | - | - |
Enoxaparin/Vitamin K-Antagonist | Phase 2 | Venous Thrombosis | - | - |
RDEA119 | Phase 2 | Advanced Cancer | - | - |
BAY86-4891 (Estradiol / Drospirenone) | Phase 2 | Contraception | - | - |
Runcaciguat (BAY1101042) | Phase 2 | Diabetic Retinopathy | - | - |
Vilaprisan (BAY1002670) | Phase 2 | Leiomyoma | - | - |
Yasminelle (SH T 00186 D) | Phase 2 | Contraceptives, Oral | - | - |
Gadobutrol~0.03 mmol/kg BW (Gadavist, Gadovist, BAY86-4875) | Phase 2 | Brain Diseases | - | - |
Gadobutrol (Gadavist,Gadovist, BAY86-4875) | Phase 2 | Myocardial Perfusion Imaging | - | - |
BAY 1753011 | Phase 2 | Heart Failure (HF) | - | - |
BAY2586116 | Phase 2 | Sleep Apnea, Obstructive | - | - |
Epoetin alfa/beta | Phase 2 | Anemia | - | - |
Taxane (Cytotoxic, BAY59-8862) | Phase 2 | Lymphoma, Non-Hodgkin | - | - |
Nexavar (Sorafenib) | Phase 2 | Breast Cancer | - | - |
Naproxen sodium/Caffeine (BAY2880376) | Phase 2 | Pain, Postoperative | - | - |
Molidustat (BAY 85-3934) | Phase 2 | Anemia | - | - |
Sagopilone (BAY86-5302, ZK 219477) | Phase 2 | Breast Neoplasms | - | - |
Adempas | Phase 2 | Chronic Thromboembolic Disease (CTED) | - | - |
Drospirenone/17ß-estradiol (Angeliq, BAY86-4891) | Phase 2 | Postmenopause | - | - |
CHOP regimen alternate with ESHAP regimen | Phase 2 | Peripheral T-cell Lymphoma | - | - |
BAY2927088_formulation A | Phase 2 | Advanced Non-small Cell Lung Cancer | - | - |
Combination drug | Phase 2 | Cancer | - | - |
BAY3427080 | Phase 2 | Post-menopausal Vasomotor Symptoms | - | - |
BAY85-8501 | Phase 2 | Bronchiectasis | - | - |
Asoprisnil (BAY86-5294) | Phase 2 | Menorrhagia | - | - |
Sorafenib and Gemcitabine | Phase 2 | Carcinoma, Hepatocellular | - | - |
SH T04769G | Phase 2 | Oral Contraceptive | - | - |
Darolutamide | Phase 2 | High-Risk Localized Prostate Cancer | - | - |
Rivaroxaban 10 MG Oral Tablet [Xarelto] | Phase 2 | Bariatric Surgery | - | - |
Eplerenone | Phase 2 | Heart Failure | - | - |
Sagopilone (ZK 219477) + prednisone | Phase 2 | Prostate Cancer | - | - |
Campath-1H | Phase 2 | Lymphoplasmacytic Lymphoma | - | - |
Sorafenib (Nexavar, BAY43-9006) plus Doxorubicin | Phase 2 | Carcinoma, Hepatocellular | - | - |
BAY1002670 | Phase 2 | Leiomyoma | - | - |
BAY3283142 | Phase 2 | Chronic Kidney Disease | - | - |
Epirubicin Hydrochloride | Phase 2 | Pleomorphic Rhabdomyosarcoma | - | - |
Sorafenib Plus Capecitabine (SorCape) | Phase 2 | Colorectal Cancer Metastatic | - | - |
Larotrectinib (Vitrakvi, BAY2757556) | Phase 2 | Solid Tumors Harboring NTRK Fusion | - | - |
Sorafenib (BAY43-9006) | Phase 2 | Carcinoma, Hepatocellular | - | - |
BAY86-9766 MEK Inhibitor + Sorafenib | Phase 2 | Carcinoma, Hepatocellular | - | - |
BAY86-9766+Gemcitabine | Phase 2 | Pancreatic Neoplasms | - | - |
BAY1902607 | Phase 2 | Cough | - | - |
Magnevist (Gadopentetate dimeglumine, BAY86-4882) | Phase 2 | Myocardial Infarction | - | - |
Spironolactone | Phase 2 | Heart Failure | - | - |
STW5 (Iberogast®, BAY98-7411) | Phase 2 | Functional Gastrointestinal Disorders | - | - |
Gadobutrol (Gadovist/Gadavist) | Phase 2 | Central Nervous System Pathology | - | - |
BAY1067197 (10 mg) | Phase 2 | Heart Failure | - | - |
Zabedosertib (BAY1834845) | Phase 2 | Atopic Dermatitis | - | - |
Piroxicam ( BAYl1902) | Phase 2 | Contraception, Postcoital | - | - |
ZK245186 | Phase 2 | Atopic Dermatitis | - | - |
Sorafenib (Nexavar, BAY43-9006) + mFOLFOX6 (5-FU, levo-leucovorin, oxaliplatin) | Phase 2 | Metastatic Colorectal Cancer | - | - |
CS1001 | Phase 2 | Advanced Refractory Solid Tumors | - | - |
Interferon beta 1b (Betaseron, BAY86-5046) | Phase 2 | Multiple Sclerosis, Relapsing-Remitting | - | - |
Capadenoson (BAY68-4986) | Phase 2 | Atrial Fibrillation | - | - |
BAY3018250 | Phase 2 | Thrombolysis | - | - |
Xarelto (Rivaroxaban, BAY59-7939) | Phase 2 | Atrial Fibrillation | - | - |
Lonaprisan (ZK 230211, BAY86-5044) | Phase 2 | Metastatic Breast Cancer | - | - |
CCR1-Antagonist (BAY86-5047, ZK811752) | Phase 2 | Endometriosis | - | - |
Sorafenib (Nexavar,BAY43-9006) | Phase 2 | Thyroid Carcinoma | - | - |
BAY2433334 | Phase 2 | Atrial Fibrillation (AF) | - | - |
Darolutamide 600 mg twice daily | Phase 2 | Prostate Cancer | - | - |
BAY98-7443 | Phase 2 | Contraception | - | - |
Fesomersen sodium (BAY2976217) | Phase 2 | End Stage Renal Disease Requiring Hemodialysis | - | - |
Sorafenib (Nexavar, BAY43-9006) + Dacarbazine (DTIC) | Phase 2 | Melanoma | - | - |
Histone Deacetylase Inhibitor, MS-275 (BAY 86-5274, ZK 244894) | Phase 2 | Melanoma | - | - |
SH D01155E | Phase 2 | Pregnancy, Unplanned | - | - |
Fulacimstat (BAY1142524) | Phase 2 | Myocardial Infarction | - | - |
Concurrent use of Radium Ra 223 dichloride and Abiraterone Acetate plus Prednisone | Phase 2 | Prostate Cancer | - | - |
BAY1193397 | Phase 2 | Diabetic Foot | - | - |
BAY2586116 (A1) | Phase 2 | Sleep Apnea, Obstructive | - | - |
Nivolumab (Opdivo) | Phase 2 | Colorectal Cancer | - | - |
lloprost(Ventavis,BAYQ6252, 20 µg/mL) | Phase 2 | Pulmonary Arterial Hypertension | - | - |
Inspra (eplerenone) | Phase 2 | Heart Failure | - | - |
Abiraterone acetate | Phase 2 | Prostate Cancer | - | - |
BAY 77-1931 | Phase 2 | Hyperphosphatemia | - | - |
Levonorgestrel IUS (BAY86-5028, G04209B) | Phase 2 | Contraception | - | - |
BAY59-8862 (Cytotoxic Taxane) | Phase 2 | Carcinoma, Non-Small-Cell Lung | - | - |
Dehydroepiandrosterone, BAY86-5314 | Phase 2 | Libido | - | - |
BAY1213790 (Osocimab) | Phase 2 | End-stage Renal Disease | - | - |
Non-active base from azelaic acid 15% gel | Phase 2 | Perioral Dermatitis | - | - |
Anetumab ravtansine (BAY94-9343) | Phase 2 | Mesothelioma | - | - |
BAY1067197 (treatment 2) | Phase 2 | Heart Failure | - | - |
Dexpanthenol foam spray, old formulation | Phase 2 | Erythema | - | - |
Gemcitabine | Phase 2 | Pancreatic Cancer | - | - |
BAY2253651 | Phase 2 | Sleep Apnea, Obstructive | - | - |
Sagopilone (BAY86-5302 , ZK219477) | Phase 2 | Ovarian Neoplasms | - | - |
Hydrocortison cream | Phase 2 | Atopic Dermatitis | - | - |
Cisplatin | Phase 2 | Renal Cell Carcinoma | - | - |
BAY60-4552 plus Vardenafil | Phase 2 | Erectile Dysfunction | - | - |
Vericiguat (BAY1021189) (5 mg) | Phase 2 | Heart Failure | - | - |
BAY2395840 | Phase 2 | Neuropathic Pain Associated With Diabetic Peripheral Neuropathy | - | - |
Phenylephrine HCl | Phase 2 | Rhinitis | - | - |
Mapracorat | Phase 2 | Atopic Dermatitis | - | - |
Etoposide | Phase 2 | Lymphoma | - | - |
emodepside | Phase 2 | Onchocerciasis | - | - |
Levonorgestrel | Phase 2 | Endometriosis | - | - |
Riociguat | Phase 2 | Scleroderma | - | - |
Darolutamide(BAY1841788, Nubeqa) | Phase 2 | Biochemically Recurrent Prostate Cancer | - | - |
Ciprofloxacin (Cipro Inhale, BAYQ3939) | Phase 2 | Cystic Fibrosis | - | - |
Vardenafil HCl (Levitra, BAY38-9456) | Phase 2 | Overactive Bladder | - | - |
Regorafenib (BAY 73-4506) | Phase 2 | Colorectal Cancer Metastatic | - | - |
Oxymetazoline HCl 0.05% nasal gel | Phase 2 | Nasal Congestion | - | - |
Copanlisib (BAY80-6946) | Phase 2 | Lymphoma Non-Hodgkin | - | - |
Ethinylestradiol/Gestogene (BAY86-5016) | Phase 2 | Contraception | - | - |
Regorafenib, (Stivarga, BAY73-4506) | Phase 2 | Solid Tumors | - | - |
Sagopilone (ZK 219477) + carboplatin | Phase 2 | Ovarian Neoplasms | - | - |
Bay 59-8862 | Phase 2 | Carcinoma, Renal Cell | - | - |
BAY2599023 (DTX201) | Phase 2 | Hemophilia A | - | - |
Sagopilone (ZK 219477) | Phase 2 | Breast Neoplasm | - | - |
Technetium Tc 99M Medronate | Phase 2 | Castration-Resistant Prostate Carcinoma | - | - |
runcaciguat | Phase 2 | Chronic Kidney Disease | - | - |
BAY73-4506 (Regorafenib, Stivarga) | Phase 2 | Solid Cancer | - | - |
E2/DRSP (BAY 86-4891) dose 1 (SH T04984E) | Phase 2 | Contraceptive, Oral, Hormonal | - | - |
BAY1817080 | Phase 2 | Overactive Bladder | - | - |
Nifedipine (Adalat CR, BAYA1040) 80mg OD | Phase 2 | Hypertension | - | - |
EV/DNG (SH T00658L) | Phase 2 | Ovulation Inhibition | - | - |
BAY2757556 (Larotrectinib, Vitrakvi) | Phase 2 | Solid Tumors Harboring NTRK Fusion | - | - |
Vericiguat (BAY1021189) (1.25 mg) | Phase 2 | Heart Failure | - | - |
BAY73-4506 | Phase 2 | Carcinoma, Hepatocellular | - | - |
UFH | Phase 2 | Cardiovascular Disease | - | - |
Vericiguat (BAY1021189) 5 mg | Phase 2 | Chronic Heart Failure With Reduced Ejection Fraction | - | - |
ZK 245186 | Phase 2 | Atopic Dermatitis | - | - |
BAY 86-5310 (ZK 283197) | Phase 2 | Vasomotor System | - | - |
Active comparator | Phase 2 | Venous Thrombosis | - | - |
Refametinib (BAY86-9766) | Phase 2 | Carcinoma, Hepatocellular | - | - |
Repinotan HCl (BAYX3702) | Phase 2 | Stroke | - | - |
BAY1142524 | Phase 2 | Heart Failure | - | - |
Neladenoson bialanate (BAY1067197) | Phase 2 | Heart Failure | - | - |
Radium-223 chloride (BAY88-8223) | Phase 2 | Breast Cancer | - | - |
Interferon | Phase 2 | Carcinoma, Renal Cell | - | - |
Capecitabine/Cisplatin + Sorafenib | Phase 2 | Malignant Neoplasm of Stomach | - | - |
ZK-EPO | Phase 2 | Melanoma | - | - |
Sagopilone 16 mg/m^2 i.v., Acetyl-L-Carnitine (ALC) 1000 mg tid, HRPC only: Prednisone or Prednisolone 5 mg bid | Phase 2 | Prostate Cancer | - | - |
Sargramostim (GM-CSF) | Phase 2 | Lymphoma | - | - |
SH T00268C | Phase 2 | Non Small Cell Lung Cancer | - | - |
Polyethylene Glycol (PEG 3350) | Phase 2 | Constipation | - | - |
Copanlisib | Phase 2 | Marginal Zone Lymphoma | - | - |
Finerenone (BAY94-8862 ) 10 mg | Phase 2 | Type 2 Diabetes Mellitus | - | - |
Radium-223 | Phase 2 | Prostate Cancer | - | - |
sorafenib tosylate | Phase 2 | Adult Primary Hepatocellular Carcinoma | - | - |
Riociguat (Adempas, BAY63-2521). | Phase 2 | Hypertension, Pulmonary | - | - |
Bifonazole spray once daily | Phase 2 | Tinea Pedis | - | - |
Interferon-α-2b | Phase 2 | Leukemia | - | - |
Elinzanetant | Phase 2 | Sleep Disturbances Associated With Menopause | - | - |
Gadopentetate dimeglumine (Magnevist, BAY86-4882, SH L 451A) | Phase 2 | Magnetic Resonance Angiography | - | - |
Dexpanthenol foam spray, new formulation | Phase 2 | Skin Abnormalities | - | - |
Naproxen Sodium (Aleve, BAY117031) | Phase 2 | Osteoarthritis, Knee | - | - |
PEG 3350 laxative plus electrolytes (PEG + E)/Macrogol (Movicol®, BAY81-8430) | Phase 2 | Constipation | - | - |
chemotherapy followed by Zevalin | Phase 2 | Diffuse Large B-cell Lymphoma | - | - |
BAY 3713372 | Phase 2 | MTAP-deleted Solid Tumors | - | - |
Vericiguat Oral Tablet | Phase 2 | Post-COVID ME/CFS | - | - |
(LMW) Heparin + Vitamin K Antagonist | Phase 2 | Venous Thromboembolism | - | - |
Betaseron (Interferon beta-1b, BAY86-5046) | Phase 2 | Multiple Sclerosis | - | - |
Rivaroxaban, (BAY59-7939) | Phase 2 | Venous Thromboembolism | - | - |
sorafenib, vorinostat and bortezomib | Phase 2 | Acute Myeloid Leukemia | - | - |
Interleukin-2 SA | Phase 2 | HIV Infections | - | - |
BAY85-3934 | Phase 2 | Anemia | - | - |
Candesartan cilexetil (Atacand), 4 mg | Phase 2 | Hypertension, Essential | - | - |
Contraception
3 drugs in this indication
chronic heart failure with preserved or mildly reduced ejection fraction
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in BAYER's drug pipeline?→
CatalystAlert tracks 374 drug candidates in BAYER's (BAYRY) pipeline across Phase 3, Phase 2. Its lead program is Low-molecular-weight heparin (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is BAYER's next FDA catalyst?→
BAYER's (BAYRY) next tracked catalyst is a Phase 3 expected August 21, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track BAYRY biotech catalysts?→
Add BAYRY to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow BAYER's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.